Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan C Oosterwijk

Showing results (91-100 of 95) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 95 results.
JAMA|April 8, 2015
Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancerTimothy R Rebbeck, Nandita Mitra, Fei Wan, et al.
Nature Genetics|January 13, 2015
Identification of six new susceptibility loci for invasive epithelial ovarian cancerKaroline B Kuchenbaecker, Susan J Ramus, Jonathan Tyrer, et al.
Gynecologic Oncology|May 6, 2015
No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer, Antoinette Hollestelle, Frederieke H van der Baan, et al.
Nature Genetics|March 29, 2013
Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancerStig E Bojesen, Karen A Pooley, Sharon E Johnatty, et al.
Nature Genetics|October 24, 2017
Identification of ten variants associated with risk of estrogen-receptor-negative breast cancerRoger L Milne, Karoline B Kuchenbaecker, Kyriaki Michailidou, et al.
Pageof 10

Showing results (91-100 of 95) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 95 results.
JAMA|April 8, 2015
Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancerTimothy R Rebbeck, Nandita Mitra, Fei Wan, et al.
Nature Genetics|January 13, 2015
Identification of six new susceptibility loci for invasive epithelial ovarian cancerKaroline B Kuchenbaecker, Susan J Ramus, Jonathan Tyrer, et al.
Gynecologic Oncology|May 6, 2015
No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer, Antoinette Hollestelle, Frederieke H van der Baan, et al.
Nature Genetics|March 29, 2013
Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancerStig E Bojesen, Karen A Pooley, Sharon E Johnatty, et al.
Nature Genetics|October 24, 2017
Identification of ten variants associated with risk of estrogen-receptor-negative breast cancerRoger L Milne, Karoline B Kuchenbaecker, Kyriaki Michailidou, et al.
Pageof 10